Attendees will hear from Peter Marks, MD, PhD, director of the FDA’s CBER, as he shares initiatives FDA is taking to accelerate approval of regenerative medicine therapies
COLUMBIA, Md., (November 7, 2024) — TEDCO, Maryland’s economic engine for technology companies, announces a fireside chat titled “Advancing Regenerative Medicine: FDA's Role in Accelerating Approvals for Innovative Therapies” that will be held at the upcoming 2024 Entrepreneur Expo at the Renaissance Baltimore Harborplace Hotel on December 4, 2024.
Join Peter Marks, PhD, director of the Food and Drug Administration (FDA)’s Center for Biologics Evaluation and Research, and Ruchika Nijhara, PhD, executive director for TEDCO's Maryland Stem Cell Research Fund (MSCRF), for an invigorating conversation about innovation in the regenerative medicine space.
“Dr. Marks is a wealth of information on the current landscape of regenerative medicine and FDA processes,” said Nijhara. “As cell and gene therapies revolutionize the treatment landscape with transformative potential for curing diseases, the FDA is proactively shaping policies to support these advancements. During his discussion, attendees can expect to learn about the latest FDA initiatives aimed at expediting the availability of these therapies, including enhanced communication with sponsors, manufacturing process standardization, and global regulatory alignment.”
MSCRF is an independent program within TEDCO established by the state of Maryland to promote stem cell research and drive scientific innovation. MSCRF provides funding and support to researchers and companies to advance scientific understanding, develop new therapies and improve patient outcomes.
TEDCO’s Entrepreneur Expo is Maryland’s premier gathering for entrepreneurs, business owners, investors and thought leaders to connect, learn and be inspired. This year’s event promises a full day of interactive workshops, insightful discussions and dynamic pitches from emerging companies.
Don’t miss your chance to gain a comprehensive understanding of the FDA’s strategies to navigate challenges in the field and support the growth of innovation! Tickets are limited, so secure your spot now and get ready for a day filled with learning, networking and inspiration.